Co-Founder & Ceo
Current4DMT (FDMT) is a clinical-stage company that harnesses the power of directed evolution for targeted genetic medicines.
2013 - Present
~13 yrs 4 mos
AeroLeads people directory · profile
David Kirn, Md Email & Phone Number
Biotech Entrepreneur, CEO, Professor, Physician-Scientist, Therapeutics Designer & Developer
at
4D Molecular Therapeutics
1 work email found
@berkeley.edu
10 phones found area 916, 415, and 510
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
Biotech Entrepreneur, CEO, Professor, Physician-Scientist, Therapeutics Designer & Developer
Location
San Francisco Bay Area, United States, United States
Who is David Kirn, Md? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
David Kirn, Md is listed as Biotech Entrepreneur, CEO, Professor, Physician-Scientist, Therapeutics Designer & Developer at 4D Molecular Therapeutics, based in San Francisco Bay Area, United States, United States. AeroLeads shows a work email signal at berkeley.edu, phone signal with area code 916, 415, 510, and a matched LinkedIn profile for David Kirn, Md.
David Kirn, Md previously worked as Co-Founder & CEO at 4D Molecular Therapeutics and Professor: BioEngineering, Molecular & Cellular Biology (Adjunct) at Uc Berkeley. David Kirn, Md holds Internal Medicine Residency, Brigham & Women'S Hospital from Harvard Medical School.
Company email context
Email format at 4D Molecular Therapeutics
This section adds company-level context without repeating David Kirn, Md's masked contact details.
*@berkeley.edu
68% confidence
AeroLeads found 1 current-domain work email signal for David Kirn, Md. Compare company email patterns before reaching out.
Profile bio
About David Kirn, Md
Physician-scientist, medicines designer/developer, professor, biotech entrepreneur & CEO. Career focus on viral vector-based therapeutics including gene therapy and oncolytic virus cancer immunotherapy. Co-founder & CEO of five viral vector-based therapeutic platform companies. Led multiple programs from design concept through Phase 3 clinical trials. UC Berkeley Professor actively teaching & mentoring students in biotech entrepreneurship. Awarded J&J Entrepreneur-Innovator and PharmaVoice100 Standout Leader award.
Listed skills include Biotechnology, Clinical Development, Oncology, Cancer, and 23 others.
Current workplace
David Kirn, Md's current company
Company context helps verify the profile and gives searchers a useful next step.
18 roles · 34 years
David Kirn, Md work experience
A career timeline built from the work history available for this profile.
Professor: Bioengineering, Molecular & Cellular Biology (Adjunct)
CurrentDirector of graduate & upper division undergraduate level course on biotechnology entrepreneurship, innovation, biopharmaceutical discovery & development and careers.
2015 - Present
~11 yrs 4 mos
Co-Founder & Board Director: Life Sciences Entrepreneurship Center
Current
2020 - Present
~6 yrs 4 mos
Lecturer & Inaugural Course Co-Director: Robinson Life Sciences Business & Entrepreneurship
Current
2019 - Present
~7 yrs 4 mos
Advisory Board Member: Bakar Bioenginuity Hub
2020 - 2021
~1 yr
Founder, Ceo & Executive Chair
Ignite Immunotherapy - A Pfizer Company
Oncolytic virus cancer immunotherapy platform and product company. Acquired by Pfizer in 2019.
2015 - 2019
~4 yrs
J & J Entrepreneur Innovator
2013 - 2015
~2 yrs
Svp, Global Clinical R&D, Hematology/Oncology
2013 - 2014
~1 yr
Founder & Ceo
Jennerex Biotherapeutics
Oncolytic virus cancer immunotherapy platform and product company. Sold (M&A) in 2013.
2003 - 2013
~10 yrs
2002 - 2008
~6 yrs
Founder & Ceo
Kirn Consulting: Viral Vector Gene Therapy, Oncolytics & Cancer Immunotherapy
Led product R&D programs for clients in cancer immunotherapy, gene therapy, oncolytic virus immunotherapy from discovery to preclinical through to Phase 3 clinical trials. Clients included: NOVARTIS (Cell Genesys partnership: oncolytic virus immunotherapy, gene therapy), BIOGEN IDEC (gene therapy, monoclonal antibody). Also consulted for BAYER, PFIZER and.
2000 - 2006
~6 yrs
Senior Advisor, Clinical R&D: Viral Vector Gene Therapy & Immunotherapy For Cancer
Led clinical clinical development of cancer gene therapy program.
2003 - 2005
~2 yrs
Senior Advisor, Clinical R&D: Oncolytic Virus Cancer Immunotherapy
Led clinical development of oncolytic virus immunotherapy programs for Novartis & Cell Genesys partnership.
2000 - 2004
~4 yrs
Associate Professor (Senior Lecturer)
Founder & Director of Cancer Biotherapeutics & Oncolytic Virotherapy R&D Program
2000 - 2003
~3 yrs
Assistant Professor (Adjunct)
1996 - 2000
~4 yrs
Vice President, Clinical / Translational R&D; Head, Oncolytic Virus Development
Joined start-up as first development employee. Started & led translational & clinical R&D for oncolytic virus immunotherapy with Onyx-015 from concept to Phase 3. Led early-phase clinical research planning for sorafenib (NEXAVAR) with partner Bayer; sorafenib became the first approved targeted agent in kidney & liver cancers. Company also discovered cdk.
1994 - 2000
~6 yrs
Fellow, Medical Oncology
1992 - 1994
~2 yrs
Mar 1992 - Jun 1992
6 education records
David Kirn, Md education
Internal Medicine Residency, Brigham & Women'S Hospital
Harvard Medical School
Doctor Of Medicine (Md), Medicine
University Of California, San Francisco
Ba, Physiology, Physical Anthropology
University Of California, Berkeley
Certificate Of Business Excellence
University Of California, Berkeley, Haas School Of Business
Masters Program: Clinical Research & Biostatistics, Clinical Research & Biostatistics
University Of California, San Francisco
Fellowship, Medical Oncology
University Of California, San Francisco
FAQ
Frequently asked questions about David Kirn, Md
Quick answers generated from the profile data available on this page.
What company does David Kirn, Md work for?
David Kirn, Md works for 4D Molecular Therapeutics.
What is David Kirn, Md's role at 4D Molecular Therapeutics?
David Kirn, Md is listed as Biotech Entrepreneur, CEO, Professor, Physician-Scientist, Therapeutics Designer & Developer at 4D Molecular Therapeutics.
What is David Kirn, Md's email address?
AeroLeads has found 1 work email signal at @berkeley.edu for David Kirn, Md at 4D Molecular Therapeutics.
What is David Kirn, Md's phone number?
AeroLeads has found 10 phone signal(s) with area code 916, 415, 510 for David Kirn, Md at 4D Molecular Therapeutics.
Where is David Kirn, Md based?
David Kirn, Md is based in San Francisco Bay Area, United States, United States while working with 4D Molecular Therapeutics.
What companies has David Kirn, Md worked for?
David Kirn, Md has worked for 4D Molecular Therapeutics, Uc Berkeley, Ignite Immunotherapy - A Pfizer Company, Johnson & Johnson, and Celgene.
How can I contact David Kirn, Md?
You can use AeroLeads to view verified contact signals for David Kirn, Md at 4D Molecular Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did David Kirn, Md attend?
David Kirn, Md holds Internal Medicine Residency, Brigham & Women'S Hospital from Harvard Medical School.
What skills is David Kirn, Md known for?
David Kirn, Md is listed with skills including Biotechnology, Clinical Development, Oncology, Cancer, Clinical Trials, Clinical Research, Pharmaceutical Industry, and Life Sciences.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial